Determination of decision limits for ACS: Systems cardiac troponin I

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 11, 2000, Pages 1155-1157

  Pagani, F ^a   Bonetti, G ^a   Stefini, F ^a   Cuccia, C ^a   Panteghini, M ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Acute myocardial infarction; Decision limits; Myocardial damage; Risk stratification; Troponin I

Indexed keywords

TROPONIN I;

ACUTE HEART INFARCTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HEART MUSCLE INJURY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REFERENCE VALUE;

HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 0034537014     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.176     Document Type: Article

References (8)

1. Introduction to coronary artery disease (CAD) and biochemical markers
2. Cardiac-specific troponins in acute coronary syndromes
3. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the use of cardiac markers in coronary artery diseases
4. Use of biochemical markers in acute coronary syndromes
5. Evaluation of the Chiron ACS: 180 automated immunoassay system for myoglobin and cardiac troponin I determination
6. Serum and plasma samples for ACS: Systems cardiac markers
7. IFCC approved recommendation on the theory of reference values. Selection of individuals for the production of reference values
8. Myocardial necrosis in "pure unstable angina" Identification of high-risk subgroups or a contradiction in terms?